In the Fall issue of the Patients as Partners Newsletter, Scott Gray, CEO discusses the key benefits of engaging patients to improve diversity in clinical trials. When clinical trial stakeholders engage patients they can overcome barriers to participation and alleviate patient uncertainty which improves patients’ experiences and increases retention.
Research teams who appreciate the unique needs of rare disease patients and invest in a white-glove approach on behalf of trial participants can reduce barriers to participation. For sponsors, clinical study teams, and site staff, this means easier patient recruitment at the beginning of a study and fewer dropouts throughout the duration of the trial—with …
Reducing Barriers to Participation in Clinical Trials for Rare Disease Read More »
Recruiting and enrolling patients is often an uphill battle for sponsors of rare and ultra-rare disease trials. The unique patient populations are located across the globe, presenting significant logistical challenges to trial sponsors and sites. The logistical and financial burdens that families face are often overwhelming. Clincierge coordinates all of the complex details related to …
Cross-Border Patient Travel: Critical Details You Don’t Want to Miss Read More »
View the results of our recent research to explore how effective patient support strategies can reduce barriers, increase retention, and improve outcomes in rare disease clinical trials in our latest eBook.
